Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/9946 |
Resumo: | Congenital heart disease (CHD) are among the leading causes of death in early childhood. Its early diagnosis is essential for good prognosis. Treatment is complex and involves the association of drugs, whose selection considers age, clinical aspects and diagnosis. Was doing a review about treatments in newborns with heart disease. The research was conducted at Biblioteca Virtual de Saúde (BVS), CAPES, PUBMED and COCHRANE. Articles were selected using the following descriptors: cardiology, neonatology, adverse effect, intensive care. We found 71 articles in the BVS, CAPES 390, PUBMED 42 and COCRHANE 1, a total of 504 articles, but 39 duplicates were eliminated resulting in 465. At the end were included 10 articles in English, Portuguese and Spanish, selected by titles and abstracts. There are few studies evaluating the drugs safety in the treatment of newborns with CHD. The most commonly used drugs are digoxin, diuretics, β-blocker and catecholamines. Other drugs are prescribed, but less frequently. Drug association demonstrated benefit for patient's clinical stabilization but increased the likelihood of drug interactions. Given the complexity and scarcity of the theme, this paper highlight the benefits and risks of CHD treatment in neonates. |
id |
UNIFEI_29f8137684ea66e24ea8df157e7bc331 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/9946 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literatureTratamiento farmacológico en pacientes neonatales con cardiopatía congénita: evidencia de la literatura recienteTratamento medicamentoso em pacientes neonatos com cardiopatia congênita: apontamentos a partir da literatura recenteCardiopatiaNeonatologiaEventos adversosCuidados críticos.Heart diseaseNeonatologyAdverse eventsCritical care.Enfermedad cardíacaNeonatologíaEventos adversosCuidado crítico.Congenital heart disease (CHD) are among the leading causes of death in early childhood. Its early diagnosis is essential for good prognosis. Treatment is complex and involves the association of drugs, whose selection considers age, clinical aspects and diagnosis. Was doing a review about treatments in newborns with heart disease. The research was conducted at Biblioteca Virtual de Saúde (BVS), CAPES, PUBMED and COCHRANE. Articles were selected using the following descriptors: cardiology, neonatology, adverse effect, intensive care. We found 71 articles in the BVS, CAPES 390, PUBMED 42 and COCRHANE 1, a total of 504 articles, but 39 duplicates were eliminated resulting in 465. At the end were included 10 articles in English, Portuguese and Spanish, selected by titles and abstracts. There are few studies evaluating the drugs safety in the treatment of newborns with CHD. The most commonly used drugs are digoxin, diuretics, β-blocker and catecholamines. Other drugs are prescribed, but less frequently. Drug association demonstrated benefit for patient's clinical stabilization but increased the likelihood of drug interactions. Given the complexity and scarcity of the theme, this paper highlight the benefits and risks of CHD treatment in neonates.Las enfermedades cardíacas congénitas (CHD) se encuentran entre las principales causas de muerte en la primera infancia. Su diagnóstico precoz es fundamental para un buen pronóstico. El tratamiento es complejo e implica la asociación de fármacos, cuya selección considera la edad, los aspectos clínicos y el diagnóstico. Estaba haciendo una revisión sobre tratamientos en recién nacidos con enfermedades cardíacas. La investigación se realizó en la Biblioteca Virtual de Saúde (BVS), CAPES, PUBMED y COCHRANE. Los artículos fueron seleccionados utilizando los siguientes descriptores: cardiología, neonatología, efectos adversos, cuidados intensivos. Encontramos 71 artículos en el BVS, CAPES 390, PUBMED 42 y COCRHANE 1, un total de 504 artículos, pero se eliminaron 39 duplicados resultando en 465. Al final se incluyeron 10 artículos en inglés, portugués y español, seleccionados por títulos y resúmenes. Hay pocos estudios que evalúen la seguridad de los medicamentos en el tratamiento de recién nacidos con CC. Los fármacos más utilizados son la digoxina, los diuréticos, los bloqueadores beta y las catecolaminas. Se recetan otros medicamentos, pero con menor frecuencia. La asociación de fármacos demostró beneficios para la estabilización clínica del paciente, pero aumentó la probabilidad de interacciones farmacológicas. Dada la complejidad y escasez del tema, este artículo destaca los beneficios y riesgos del tratamiento de las enfermedades del corazón en los recién nacidos.Alterações cardíacas congênitas (CC) estão entre as principais causas de morte na primeira infância e o diagnóstico precoce é essencial para um bom prognóstico. O tratamento é complexo e envolve associação de fármacos, cuja seleção considera fatores como idade, clínica e diagnóstico. Realizar uma revisão dos tratamentos medicamentosos adotados em CC neonatal. Pesquisa em base de dados de artigos relacionados ao tema, com os descritores: “cardiology”,”neonatology”,”adverse effect”, “intensive care”. Resultando na BVS 71 artigos, CAPES 390, PUBMED 42 e COCRHANE 1, totalizando 504 artigos, eliminados 39 por duplicatas, restando 465. Nos demais analisou-se títulos e resumos para detectar aqueles abordavam o tema em português, inglês e espanhol, finalizando em 10 artigos para revisão. Há escassez de trabalhos que avaliaram o uso de fármacos em neonatos com CC. Os mais utilizados foram digoxina, diuréticos, β-bloqueadores e catecolaminas, outros foram prescritos, mas em menor frequência. A associação de fármacos demonstrou benefício na clínica do paciente, bem como elevou a probabilidade de interações medicamentosas. Diante da complexidade e escassez do tema, o estudo não pretende esgotar a discussão, entretanto irá ressaltar benefícios e riscos de sua utilização em neonatos com CC.Research, Society and Development2020-11-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/994610.33448/rsd-v9i11.9946Research, Society and Development; Vol. 9 No. 11; e3339119946Research, Society and Development; Vol. 9 Núm. 11; e3339119946Research, Society and Development; v. 9 n. 11; e33391199462525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/9946/8835Copyright (c) 2020 Maryllia Suellem Almeida Cesario; Alexandre Mansuê Ferreira Carneiro; Maria Fâni Dolabelahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCesario, Maryllia Suellem Almeida Carneiro, Alexandre Mansuê Ferreira Dolabela, Maria Fâni 2020-12-10T23:37:57Zoai:ojs.pkp.sfu.ca:article/9946Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:32:07.254412Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature Tratamiento farmacológico en pacientes neonatales con cardiopatía congénita: evidencia de la literatura reciente Tratamento medicamentoso em pacientes neonatos com cardiopatia congênita: apontamentos a partir da literatura recente |
title |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
spellingShingle |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature Cesario, Maryllia Suellem Almeida Cardiopatia Neonatologia Eventos adversos Cuidados críticos. Heart disease Neonatology Adverse events Critical care. Enfermedad cardíaca Neonatología Eventos adversos Cuidado crítico. |
title_short |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
title_full |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
title_fullStr |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
title_full_unstemmed |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
title_sort |
Drug treatment in neonatal patients with congenital heart disease: evidence from recent literature |
author |
Cesario, Maryllia Suellem Almeida |
author_facet |
Cesario, Maryllia Suellem Almeida Carneiro, Alexandre Mansuê Ferreira Dolabela, Maria Fâni |
author_role |
author |
author2 |
Carneiro, Alexandre Mansuê Ferreira Dolabela, Maria Fâni |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Cesario, Maryllia Suellem Almeida Carneiro, Alexandre Mansuê Ferreira Dolabela, Maria Fâni |
dc.subject.por.fl_str_mv |
Cardiopatia Neonatologia Eventos adversos Cuidados críticos. Heart disease Neonatology Adverse events Critical care. Enfermedad cardíaca Neonatología Eventos adversos Cuidado crítico. |
topic |
Cardiopatia Neonatologia Eventos adversos Cuidados críticos. Heart disease Neonatology Adverse events Critical care. Enfermedad cardíaca Neonatología Eventos adversos Cuidado crítico. |
description |
Congenital heart disease (CHD) are among the leading causes of death in early childhood. Its early diagnosis is essential for good prognosis. Treatment is complex and involves the association of drugs, whose selection considers age, clinical aspects and diagnosis. Was doing a review about treatments in newborns with heart disease. The research was conducted at Biblioteca Virtual de Saúde (BVS), CAPES, PUBMED and COCHRANE. Articles were selected using the following descriptors: cardiology, neonatology, adverse effect, intensive care. We found 71 articles in the BVS, CAPES 390, PUBMED 42 and COCRHANE 1, a total of 504 articles, but 39 duplicates were eliminated resulting in 465. At the end were included 10 articles in English, Portuguese and Spanish, selected by titles and abstracts. There are few studies evaluating the drugs safety in the treatment of newborns with CHD. The most commonly used drugs are digoxin, diuretics, β-blocker and catecholamines. Other drugs are prescribed, but less frequently. Drug association demonstrated benefit for patient's clinical stabilization but increased the likelihood of drug interactions. Given the complexity and scarcity of the theme, this paper highlight the benefits and risks of CHD treatment in neonates. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-11-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/9946 10.33448/rsd-v9i11.9946 |
url |
https://rsdjournal.org/index.php/rsd/article/view/9946 |
identifier_str_mv |
10.33448/rsd-v9i11.9946 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/9946/8835 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 11; e3339119946 Research, Society and Development; Vol. 9 Núm. 11; e3339119946 Research, Society and Development; v. 9 n. 11; e3339119946 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052742672318464 |